This inventor holds 4 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignees: Arsanis Biosciences Gmbh, X4 Pharmaceuticals (Austria) Gmbh. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2021
Title: Zoltán Magyarics: Innovator in Antibody Development
Introduction
Zoltán Magyarics is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting multi-drug resistant strains of bacteria. With a total of 4 patents to his name, his work is crucial in advancing medical diagnostics and treatments.
Latest Patents
Among his latest patents is the development of an MDR-specific antibody. This invention relates to an isolated antibody that specifically binds to the O25b antigen of multi-drug resistant (MDR) strains. The patent details its medical and diagnostic use, the method of producing the antibody, and includes an isolated nucleotide sequence, plasmids, and host cells used in the production process. Additionally, it covers an isolated epitope recognized by the specific antibody.
Career Highlights
Zoltán has worked with notable companies in the biotechnology sector, including Arsanis Biosciences GmbH and X4 Pharmaceuticals (Austria) GmbH. His experience in these organizations has allowed him to collaborate on innovative projects that push the boundaries of medical science.
Collaborations
Some of his coworkers include Eszter Nagy and Gábor Nagy, who have contributed to his research and development efforts. Their collaboration has been instrumental in advancing the projects they have worked on together.
Conclusion
Zoltán Magyarics is a key figure in the field of antibody research, with a focus on combating multi-drug resistant infections. His innovative patents and collaborations highlight his commitment to improving medical diagnostics and treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile